دورية أكاديمية

Targeting phosphorylation circuits on CREB and CRTCs as the strategy to prevent acquired skin hyperpigmentation.

التفاصيل البيبلوغرافية
العنوان: Targeting phosphorylation circuits on CREB and CRTCs as the strategy to prevent acquired skin hyperpigmentation.
المؤلفون: Kim SH; College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea., Na C; College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea., Yun CY; College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea.; R&D Center, The Skin's Co. Ltd, Jecheon 27116, Korea., Kim JG; College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea., Baek ST; R&D Center, The Skin's Co. Ltd, Jecheon 27116, Korea., An HJ; R&D Center, Yeomyung Biochem Co. Ltd, Cheongju 28172, Korea., Lee JD; R&D Center, Yeomyung Biochem Co. Ltd, Cheongju 28172, Korea., Lee SW; College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea., Jung JK; College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea., Hwang BY; College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea., Han SB; College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea., Kim Y; College of Pharmacy, Chungbuk National University, Cheongju 28160, Korea.
المصدر: International journal of biological sciences [Int J Biol Sci] 2024 Jan 01; Vol. 20 (1), pp. 312-330. Date of Electronic Publication: 2024 Jan 01 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Ivyspring International Country of Publication: Australia NLM ID: 101235568 Publication Model: eCollection Cited Medium: Internet ISSN: 1449-2288 (Electronic) Linking ISSN: 14492288 NLM ISO Abbreviation: Int J Biol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Lake Haven, N.S.W., Australia : Ivyspring International, c2004-
مواضيع طبية MeSH: Melanins*/metabolism , Hyperpigmentation*/metabolism, Humans ; Animals ; Mice ; Cyclic AMP Response Element-Binding Protein/metabolism ; Phosphorylation ; alpha-MSH/metabolism ; AMP-Activated Protein Kinases/metabolism ; Melanocytes/metabolism ; Microphthalmia-Associated Transcription Factor/genetics ; Microphthalmia-Associated Transcription Factor/metabolism ; Cell Line, Tumor
مستخلص: Background: The cAMP response element-binding protein (CREB) and CREB-regulated transcription coactivators (CRTCs) cooperate in the transcriptional activation of microphthalmia-associated transcription factor subtype M (MITF-M) that is a master regulator in the biogenesis, pigmentation and transfer of melanosomes at epidermal melanocytes. Here, we propose the targeting of phosphorylation circuits on CREB and CRTCs in the expression of MITF-M as the rationale to prevent skin hyperpigmentation by elucidating the inhibitory activity and mechanism of yakuchinone A (Yaku A) on facultative melanogenesis. Methods: We employed human epidermal melanocyte cell, mouse skin, and mouse melanoma cell, and applied Western blotting, reverse transcription-polymerase chain reaction, immunoprecipitation and confocal microscopy to conduct this study. Results: This study suggested that α-melanocyte stimulating hormone (α-MSH)-induced melanogenic programs could switch on the axis of protein kinase A-salt inducible kinases (PKA-SIKs) rather than that of PKA-AMP activated protein kinase (PKA-AMPK) during the dephosphorylation of CRTCs in the expression of MITF-M. SIK inhibitors rather than AMPK inhibitors stimulated melanin production in melanocyte cultures in the absence of extracellular melanogenic stimuli, wherein SIK inhibitors increased the dephosphorylation of CRTCs but bypassed the phosphorylation of CREB for the expression of MITF-M. Treatment with Yaku A prevented ultraviolet B (UV-B)-irradiated skin hyperpigmentation in mice and inhibited melanin production in α-MSH- or SIK inhibitor-activated melanocyte cultures. Mechanistically, Yaku A suppressed the expression of MITF-M via dually targeting the i) cAMP-dependent dissociation of PKA holoenzyme at the upstream from PKA-catalyzed phosphorylation of CREB coupled with PKA-SIKs axis-mediated dephosphorylation of CRTCs in α-MSH-induced melanogenic programs, and ii) nuclear import of CRTCs after SIK inhibitor-induced dephosphorylation of CRTCs. Conclusions: Taken together, the targeting phosphorylation circuits on CREB and CRTCs in the expression of MITF-M could be a suitable strategy to prevent pigmentary disorders in the skin.
Competing Interests: Competing Interests: The authors have declared that no competing interest exists.
(© The author(s).)
References: Cell Mol Life Sci. 2015 Apr;72(7):1249-60. (PMID: 25433395)
Pigment Cell Melanoma Res. 2019 Mar;32(2):224-236. (PMID: 30019545)
Cell Rep. 2017 Jun 13;19(11):2177-2184. (PMID: 28614705)
Pigment Cell Res. 2000 Apr;13(2):60-9. (PMID: 10841026)
J Investig Dermatol Symp Proc. 2001 Nov;6(1):99-104. (PMID: 11764295)
Proteins. 2006 Aug 15;64(3):749-57. (PMID: 16761278)
Ageing Res Rev. 2021 Aug;69:101349. (PMID: 33984527)
Photochem Photobiol. 2008 Mar-Apr;84(2):501-8. (PMID: 18282187)
J Am Acad Dermatol. 2023 Feb;88(2):271-288. (PMID: 35151757)
Exp Dermatol. 2021 Apr;30(4):560-571. (PMID: 33320376)
Chemistry. 2018 Jan 2;24(1):47-55. (PMID: 29052256)
Photodermatol Photoimmunol Photomed. 2019 Nov;35(6):387-392. (PMID: 31206816)
Theranostics. 2021 Oct 17;11(20):9918-9936. (PMID: 34815795)
Mol Cell Biochem. 2021 Mar;476(3):1401-1409. (PMID: 33389492)
Biol Pharm Bull. 1994 Feb;17(2):266-9. (PMID: 8205125)
J Invest Dermatol. 2013 Apr;133(4):1072-9. (PMID: 23254773)
Int J Cosmet Sci. 2018 Aug;40(4):328-347. (PMID: 29752874)
Theranostics. 2019 Jan 21;9(3):646-660. (PMID: 30809299)
Pigment Cell Melanoma Res. 2017 Jan;30(6):553-557. (PMID: 28481450)
Postepy Hig Med Dosw (Online). 2016 Jun 30;70(0):695-708. (PMID: 27356601)
Nat Rev Mol Cell Biol. 2011 Mar;12(3):141-51. (PMID: 21346730)
Curr Opin Genet Dev. 2017 Aug;45:132-138. (PMID: 28605672)
Cells. 2022 Jan 17;11(2):. (PMID: 35053423)
Biochem J. 2021 Apr 16;478(7):1377-1397. (PMID: 33861845)
Mol Pharmacol. 2022 Apr;101(4):219-225. (PMID: 34330820)
Cell Rep. 2021 May 18;35(7):109136. (PMID: 34010639)
Mol Cell Biochem. 2011 Aug;354(1-2):241-6. (PMID: 21519923)
Br J Pharmacol. 2015 Jul;172(13):3434-45. (PMID: 25766244)
Pigment Cell Melanoma Res. 2010 Dec;23(6):809-19. (PMID: 20819186)
Curr Opin Cell Biol. 2017 Apr;45:31-37. (PMID: 28232179)
Trends Cancer. 2019 Feb;5(2):111-127. (PMID: 30755304)
Adv Exp Med Biol. 2017;996:89-104. (PMID: 29124693)
Trends Genet. 2017 May;33(5):303-321. (PMID: 28365140)
J Neuroendocrinol. 2008 Jun;20(6):692-9. (PMID: 18601691)
Front Endocrinol (Lausanne). 2018 Sep 12;9:538. (PMID: 30258407)
Exp Dermatol. 2010 Jul 1;19(7):617-27. (PMID: 20201954)
PLoS One. 2017 Feb 24;12(2):e0173013. (PMID: 28235073)
Cell. 2007 Mar 9;128(5):853-64. (PMID: 17350573)
Curr Biol. 2004 Dec 14;14(23):2156-61. (PMID: 15589160)
Genes Dev. 2019 Aug 1;33(15-16):983-1007. (PMID: 31123060)
Life Sci. 2002 Sep 20;71(18):2171-9. (PMID: 12204775)
iScience. 2019 Jan 25;11:134-145. (PMID: 30611118)
Pigment Cell Melanoma Res. 2017 Sep;30(5):454-466. (PMID: 28649789)
Cancer Res. 1980 Dec;40(12):4694-703. (PMID: 7438101)
Theranostics. 2020 Mar 4;10(9):4017-4029. (PMID: 32226536)
فهرسة مساهمة: Keywords: Melanogenesis; SIK inhibitor; UV-B; Yaku A; α-MSH
المشرفين على المادة: 0 (Melanins)
0 (Cyclic AMP Response Element-Binding Protein)
581-05-5 (alpha-MSH)
EC 2.7.11.31 (AMP-Activated Protein Kinases)
0 (Microphthalmia-Associated Transcription Factor)
تواريخ الأحداث: Date Created: 20240102 Date Completed: 20240103 Latest Revision: 20240306
رمز التحديث: 20240306
مُعرف محوري في PubMed: PMC10750286
DOI: 10.7150/ijbs.86536
PMID: 38164184
قاعدة البيانات: MEDLINE
الوصف
تدمد:1449-2288
DOI:10.7150/ijbs.86536